UnitedHealth Group Incorporated (UNH)
NYSE: UNH · Real-Time Price · USD
282.65
-5.42 (-1.88%)
At close: Jul 18, 2025, 4:00 PM
282.60
-0.05 (-0.02%)
After-hours: Jul 18, 2025, 7:59 PM EDT
UnitedHealth Group Stock Forecast
Stock Price Forecast
The 24 analysts that cover UnitedHealth Group stock have a consensus rating of "Buy" and an average price target of $426.48, which forecasts a 50.89% increase in the stock price over the next year. The lowest target is $270 and the highest is $700.
Price Target: $426.48 (+50.89%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for UnitedHealth Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 6 | 6 | 5 |
| Buy | 12 | 12 | 14 | 15 | 14 | 14 |
| Hold | 2 | 2 | 2 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 23 | 25 | 25 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $360 → $345 | Strong Buy | Maintains | $360 → $345 | +22.06% | Jul 16, 2025 |
| Barclays | Barclays | Buy Maintains $350 → $337 | Buy | Maintains | $350 → $337 | +19.23% | Jul 9, 2025 |
| UBS | UBS | Strong Buy Maintains $400 → $385 | Strong Buy | Maintains | $400 → $385 | +36.21% | Jun 25, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $405 → $418 | Buy | Maintains | $405 → $418 | +47.89% | Jun 20, 2025 |
| Baird | Baird | Buy → Hold Downgrades $356 → $312 | Buy → Hold | Downgrades | $356 → $312 | +10.38% | Jun 11, 2025 |
Financial Forecast
Revenue This Year
454.00B
from 400.28B
Increased by 13.42%
Revenue Next Year
482.95B
from 454.00B
Increased by 6.38%
EPS This Year
22.32
from 15.51
Increased by 43.88%
EPS Next Year
25.86
from 22.32
Increased by 15.86%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 481.2B | 515.0B | 558.0B | ||
| Avg | 454.0B | 483.0B | 517.5B | ||
| Low | 430.6B | 445.0B | 482.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 20.2% | 13.4% | 15.5% | ||
| Avg | 13.4% | 6.4% | 7.2% | ||
| Low | 7.6% | -2.0% | -0.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 27.76 | 32.03 | 35.68 | ||
| Avg | 22.32 | 25.86 | 29.56 | ||
| Low | 17.64 | 21.56 | 24.84 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 79.0% | 43.5% | 38.0% | ||
| Avg | 43.9% | 15.9% | 14.3% | ||
| Low | 13.7% | -3.4% | -3.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.